Germantown, MD, United States of America

Norman Eugene Ohler


Average Co-Inventor Count = 5.9

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • Germantown, MD (US) (2004)
  • New Market, MD (US) (2005 - 2006)

Company Filing History:


Years Active: 2004-2006

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Celebrating the Innovations of Norman Eugene Ohler

Introduction

Norman Eugene Ohler, an accomplished inventor based in Germantown, MD, has made significant contributions to the field of pharmaceuticals and chemical agents. With a total of three patents to his name, Ohler has specialized in developing innovative compounds that modulate gene expression and inhibit metalloproteases, leading to potential breakthroughs in medical treatments.

Latest Patents

Ohler's latest patents represent cutting-edge advancements in therapeutic agents. The first patent focuses on derivatives of 3-hydroxy-pyrrole-2,4-dicarboxylic acid and their uses in modulating gene expression in cellular systems, particularly in cancer cells. This innovation includes the development of chemical agents that can serve as active ingredients in pharmaceutical compositions, providing methods for their preparation and application as therapeutic agents.

His second patent involves novel heterocyclic side chain-containing n-substituted metalloprotease inhibitors. These compounds are designed to treat conditions characterized by excessive activity of metalloproteases, with a structural framework that allows for various modifications and bioavailability. The patent outlines both the compounds themselves and pharmaceutical compositions that leverage these structures to facilitate treatment for metalloprotease-related maladies.

Career Highlights

Throughout his career, Norman Eugene Ohler has worked at prominent companies such as Procter & Gamble and Avalon Pharmaceuticals. His experiences within these organizations have undoubtedly shaped his expertise in drug development and innovation in chemical compounds. His ability to create valuable solutions in the pharmaceutical field showcases his talents as an inventor and his commitment to advancing health sciences.

Collaborations

Ohler has collaborated with distinguished coworkers like Stanislaw Pikul and Neil Gregory Almstead. These collaborations have likely provided him with a platform to exchange ideas and foster innovative thinking, further enhancing the impact of his work within the industry.

Conclusion

Norman Eugene Ohler's inventions reflect his dedication to improving therapeutic options through innovative chemical solutions. With his patents offering promising avenues for cancer treatment and conditions related to metalloprotease activity, his work stands as a testament to the power of innovation in advancing medical science. Ohler remains a notable figure in the realm of inventors, and his continued contributions will likely pave the way for future discoveries in pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…